Microbix Biosystems Inc. focuses on developing and commercializing biological products and technologies through leveraging its Core Base Business of developing infectious disease antigens (virology) for sale to large diagnostic kit manufacturers. The Company has initiated a three-pronged strategy to convert itself from a virology/antigen and water solutions manufacturing company into a high-growth biotechnology firm. Microbix is progressing towards a break-through for one, if not two, of its large-market development products over the next six to eight months. The Microbix story is one where management has taken a core business in virology and water solutions products and used the proceeds to develop or acquire high-potential, large-market products to serve a variety of health-science segments. The Company is now on the cusp of reaping the benefits of years of development. For more detail, read the report here: Microbix Biosystems eResearch posts all its reports and articles on its website, www.eresearch.ca, and subscription is FREE. eResearch is a primary source for professional investment research, focused primarily on small- and mid-cap companies. Our research and analysis is of institutional quality, and has the potential for reaching millions of global investors through our extensive electronic distribution network. Contact:eResearch: Bob Weir, CFA, Director of Research Telephone: (416) 703-6258 Ext 221; E-mail: bweir@eresearch.ca